Francesco Puma

Francesco Puma

Auto-generated profile, based on publicly available information

Francesco Puma

Department of Thoracic Surgery, University of Perugia Medical School, Perugia, Italy

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in JACC
Verified
Journal Article
Closed access
RRReitze Rodseth
Reitze Rodseth
BBBruce M. Biccard
Bruce M. Biccard
YMYannick Le Manach
Yannick Le Manach
DSDaniel I. Sessler
Daniel I. Sessler
GBGiovana A. Lurati Buse
Giovana A. Lurati Buse
PDPhilip J Devereaux
Philip J Devereaux

7 November 2007 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RRRafael Rosell
Rafael Rosell
MSMarcin Skrzypski
Marcin Skrzypski
EJEwa Jassem
Ewa Jassem
MTMiquel Taron
Miquel Taron
RBRoberta Bartolucci
Roberta Bartolucci
JJJacek Jassem
Jacek Jassem
Although early-stage non-small-cell lung cancer (NSCLC) is considered a potentially curable disease following complete resection, patients have a wide spectrum of survival according to stage (IB, II, IIIA). Within each stage, gene expression profiles can identify patients with a higher risk of recurrence. We hypothesized that altered mRNA expression in nine genes could help to predict disease outcome: excision repair cross-complementing 1 (ERCC1), myeloid zinc finger 1 (MZF1) and Twist1 (which regulate N-cadherin expression), ribonucleotide reductase subunit M1 (RRM1), thioredoxin-1 (TRX1), tyrosyl-DNA phosphodiesterase (Tdp1), nuclear factor of activated T cells (NFAT), BRCA1, and the human homolog of yeast budding uninhibited by benzimidazole (BubR1). We performed real-time quantitative polymerase chain reaction (RT-QPCR) in frozen lung cancer tissue specimens from 126 chemonaive NSCLC patients who had undergone surgical resection and evaluated the association between gene expression levels and survival. For validation, we used paraffin-embedded specimens from 58 other NSCLC patients. A strong inter-gene correlation was observed between expression levels of all genes except NFAT. A Cox proportional hazards model indicated that along with disease stage, BRCA1 mRNA expression significantly correlated with overall survival (hazard ratio [HR], 1.98 [95% confidence interval (CI), 1.11-6]; P = 0.02). In the independent cohort of 58 patients, BRCA1 mRNA expression also significantly correlated with survival (HR, 2.4 [95%CI, 1.01-5.92]; P = 0.04). Overexpression of BRCA1 mRNA was strongly associated with poor survival in NSCLC patients, and the validation of this finding in an independent data set further strengthened this association. Since BRCA1 mRNA expression has previously been linked to differential sensitivity to cisplatin and antimicrotubule drugs, BRCA1 mRNA expression may provide additional information for customizing adjuvant antimicrotubule-based chemotherapy, especially in stage IB, where the role of adjuvant chemotherapy has not been clearly demonstrated.

1 May 2005 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PFP. Ferolla
P. Ferolla
ALBERTO FALCHETTIALBERTO FALCHETTI
ALBERTO FALCHETTI
PFPier Luigi Filosso
Pier Luigi Filosso
PTP. Tomassetti
P. Tomassetti
GTG. Tamburrano
G. Tamburrano
MBM. L. Brandi
M. L. Brandi
Neuroendocrine tumors may occur in the setting of multiple endocrine neoplasia type 1 (MEN1) syndrome. Among these, a probably underestimated prevalence of well differentiated neuroendocrine thymic carcinoma (carcinoid), a neoplasm characterized by very aggressive behavior, has been described. We report characterization of the seven Italian cases in which this association occurred among a series of 221 MEN1 patients (41 sporadic and 180 familial cases; prevalence, 3.1%). All of the patients were male, and six of seven (85%) were heavy smokers. No associated hormonal hypersecretion was detected. The first diagnosis was between the second and fifth decades. Familial clusters were present in three of seven (42.8%). No genotype-phenotype correlation was found. All seven cases were associated with hyperparathyroidism. In one patient, prophylactic thymectomy revealed a small nodular lesion suggestive of a thymic carcinoid, providing evidence that preventive thymectomy might prevent additional growth of an occult thymic carcinoid. These findings confirm that thymic carcinoids are associated with a very high lethality, with a near-total prevalence in smoker males. Therefore, prophylactic thymectomy should be considered at neck surgery for primary hyperparathyroidism in MEN1 male patients, especially for smokers, and, due to the frequent familial clusters distribution of this pathology, in subjects with affected relatives presenting this feature. Thus, we recommend screening every patient affected with a neuroendocrine thymic neoplasm for MEN1 syndrome.

1 February 2006 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
SBStefania Brozzetti
Stefania Brozzetti
GMGianluca Mazzoni
Gianluca Mazzoni
MMMichelangelo Miccini
Michelangelo Miccini
FPFrancesco Puma
Francesco Puma
MAMonica De Angelis
Monica De Angelis
ACAntonino Cavallaro
Antonino Cavallaro
Research from JAMA Surgery — Surgical Treatment of Pancreatic Head Carcinoma in Elderly Patients

1 March 2009 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PDF file
PFPiero Ferolla
Piero Ferolla
NDNiccolò Daddi
Niccolò Daddi
MUMoira Urbani
Moira Urbani
ASAntonia Semeraro
Antonia Semeraro
RRRodolfo Ribacchi
Rodolfo Ribacchi
GDGiuliano Daddi
Giuliano Daddi

1 December 2000 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
FPFrancesco Puma
Francesco Puma
MRMark Ragusa
Mark Ragusa
NANicola Avenia
Nicola Avenia
MUMoira Urbani
Moira Urbani
ADAndrea Droghetti
Andrea Droghetti
GDGiuliano Daddi
Giuliano Daddi